TRENANTONE Side Effects

7014453-6 | Renal Failure
on Sep 17, 2010 Male patient from AUSTRIA , 77 years of age, was diagnosed with prostate cancer metastatic and was treated with Trenantone (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure. Trenantone dosage: .

7006393-3 | Cerebellar Infarction
Patient was taking Trenantone (View Usage). Patient had the following side effects: cerebellar infarction on Sep 08, 2010 from AUSTRIA Additional patient health information: Male patient , 82 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Trenantone dosage: . Patient was hospitalized and became disabled.

7003401-0 | Renal Failure
Adverse event was reported on Sep 13, 2010 by a Male patient taking Trenantone (View Usage) (Dosage: ) was diagnosed with prostate cancer metastatic and. Location: AUSTRIA , 77 years of age, After Trenantone was administered, patient had the following side effects: renal failure.

6516583-1 | Cerebral Haemorrhage
on Dec 15, 2009 Male patient from JAPAN , 58 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trenantone (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Trenantone dosage: . Patient was hospitalized and became disabled.


6476841-6 | Cerebrovascular Accident
on Nov 27, 2009 Male patient from JAPAN , 58 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trenantone (View Usage). Patient had the following side effects: cerebrovascular accident. Trenantone dosage: . Patient was hospitalized and became disabled.

6409814-X | Anaemia
Patient was taking Trenantone (View Usage). After Trenantone was administered, patient had the following side effects: anaemia on Oct 12, 2009 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Trenantone dosage: . Patient was hospitalized.

6393177-2 | Marasmus
Adverse event was reported on Oct 01, 2009 by a Male patient taking Trenantone (View Usage) (Dosage: ) was diagnosed with prostate cancer metastatic and. Location: JAPAN , 94 years of age, Patient experienced the following unwanted or unexpected effects: marasmus.

6393127-9 | Anaemia
on Sep 28, 2009 Male patient from JAPAN , 76 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trenantone (View Usage). Patient had the following side effects: anaemia. Trenantone dosage: . Patient was hospitalized.

6383060-0 | Bladder Cancer
on Sep 24, 2009 Male patient from JAPAN , 76 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trenantone (View Usage). After Trenantone was administered, patient had the following side effects: bladder cancer (What is bladder cancer?). Trenantone dosage: .

6375367-8 | Marasmus
Patient was taking Trenantone (View Usage). Patient experienced the following unwanted or unexpected effects: marasmus on Sep 15, 2009 from JAPAN Additional patient health information: Male patient , 94 years of age, was diagnosed with prostate cancer metastatic and. Trenantone dosage: .

6355578-8 | Bladder Cancer
Adverse event was reported on Sep 02, 2009 by a Male patient taking Trenantone (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: JAPAN , 76 years of age, Patient had the following side effects: bladder cancer (What is bladder cancer?).

6339464-5 | Muscular Weakness, Oedema Peripheral, Papilloedema
on Aug 25, 2009 Male patient from JAPAN , 78 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trenantone (View Usage). After Trenantone was administered, patient had the following side effects: muscular weakness, oedema peripheral, papilloedema. Trenantone dosage: . Patient was hospitalized.

6327082-4 | Muscular Weakness, Oedema Peripheral, Papilloedema
on Aug 15, 2009 Male patient from JAPAN , 78 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trenantone (View Usage). Patient experienced the following unwanted or unexpected effects: muscular weakness, oedema peripheral, papilloedema. Trenantone dosage: . Patient was hospitalized.

6270682-0 | Prostate Cancer
Patient was taking Trenantone (View Usage). Patient had the following side effects: prostate cancer (What is prostate cancer?) on Jul 06, 2009 from GERMANY Additional patient health information: Male patient , 68 years of age, was diagnosed with prostate cancer metastatic and. Trenantone dosage: .

6267671-9 | Prostate Cancer
Adverse event was reported on Jul 06, 2009 by a Male patient taking Trenantone (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: JAPAN , 70 years of age, After Trenantone was administered, patient had the following side effects: prostate cancer (What is prostate cancer?).

6222257-7 | Injection Site Pain, Injection Site Swelling, Prostatic Specific Antigen Increased
on Jun 04, 2009 Male patient from GERMANY , 60 years of age, was diagnosed with neoplasm prostate and was treated with Trenantone (View Usage). Patient experienced the following unwanted or unexpected effects: injection site pain, injection site swelling, prostatic specific antigen increased. Trenantone dosage: .

6214226-8 | Hot Flush, Venous Thrombosis Limb
on May 27, 2009 Male patient from GERMANY , 87 years of age, was diagnosed with prostate cancer metastatic and was treated with Trenantone (View Usage). Patient had the following side effects: hot flush, venous thrombosis limb. Trenantone dosage: .

6213220-0 | Brain Neoplasm
Patient was taking Trenantone (View Usage). After Trenantone was administered, patient had the following side effects: brain neoplasm on May 26, 2009 from GERMANY Additional patient health information: Male patient , 82 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Trenantone dosage: .

6166307-5 | Bone Pain, Prostate Cancer
Adverse event was reported on Apr 21, 2009 by a Male patient taking Trenantone (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: GERMANY , weighting 242.5 lb, Patient experienced the following unwanted or unexpected effects: bone pain, prostate cancer (What is prostate cancer?). During the same period patient was treated with ANTIANDROGENS (View Antiandrogens Review and Antiandrogens Label ), NOVALGIN (View Novalgin Review and Novalgin Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ).

6143717-3 |
on Apr 01, 2009 Male patient from GERMANY , weighting 185.2 lb, was diagnosed with prostate cancer metastatic and was treated with Trenantone (View Usage). . Trenantone dosage: .

6109159-1 | Prostate Cancer
on Mar 05, 2009 Male patient from GERMANY , weighting 183.0 lb, was diagnosed with prostate cancer metastatic and was treated with Trenantone (View Usage). After Trenantone was administered, patient had the following side effects: prostate cancer (What is prostate cancer?). Trenantone dosage: .

6103876-5 | Prostate Cancer
Patient was taking Trenantone (View Usage). Patient experienced the following unwanted or unexpected effects: prostate cancer (What is prostate cancer?) on Feb 26, 2009 from GERMANY Additional patient health information: Male patient , weighting 183.0 lb, was diagnosed with prostate cancer metastatic and. Trenantone dosage: .

6076731-7 |
Adverse event was reported on Feb 08, 2009 by a Male patient taking Trenantone (View Usage) (Dosage: ) was diagnosed with prostate cancer metastatic and. Location: GERMANY , weighting 207.2 lb, .

6003580-8 | Injection Site Pain, Injection Site Swelling, Prostatic Specific Antigen Increased
on Dec 04, 2008 Male patient from GERMANY , 60 years of age, was diagnosed with neoplasm prostate and was treated with Trenantone (View Usage). After Trenantone was administered, patient had the following side effects: injection site pain, injection site swelling, prostatic specific antigen increased. Trenantone dosage: .

5983747-5 | Myelodysplastic Syndrome
on Nov 28, 2008 Male patient from JAPAN , 72 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trenantone (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome. Trenantone dosage: .

5923641-9 | Injection Site Pain, Injection Site Swelling, Prostatic Specific Antigen Increased
Patient was taking Trenantone (View Usage). Patient had the following side effects: injection site pain, injection site swelling, prostatic specific antigen increased on Oct 07, 2008 from GERMANY Additional patient health information: Male patient , 60 years of age, was diagnosed with neoplasm prostate and. Trenantone dosage: .

5920804-3 | Injection Site Pain, Injection Site Swelling, Prostatic Specific Antigen Increased
Adverse event was reported on Oct 07, 2008 by a Male patient taking Trenantone (View Usage) (Dosage: ) was diagnosed with neoplasm prostate and. Location: GERMANY , 60 years of age, After Trenantone was administered, patient had the following side effects: injection site pain, injection site swelling, prostatic specific antigen increased.

5133019-6 | Adrenal Mass, Arteriosclerosis, Bladder Disorder, Calcinosis, Dysuria, Emphysema, Gastroenteritis Radiation, Hepatic Cirrhosis
on Oct 13, 2006 Male patient from GERMANY , 66 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trenantone (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal mass, arteriosclerosis, bladder disorder, calcinosis, dysuria, emphysema, gastroenteritis radiation, hepatic cirrhosis. Trenantone dosage: 11.25 Mg,1 In 3 M. During the same period patient was treated with HCT BETA (HYDROCHLOROTHIAZIDE) (View Hct Beta (hydrochlorothiazide) Review and Hct Beta (hydrochlorothiazide) Label ), CORVO (ENALAPRIL MALEATE) (View Corvo (enalapril Maleate) Review and Corvo (enalapril Maleate) Label ), SALOSPIR (ACETYLSALICYLIC ACID) (View Salospir (acetylsalicylic Acid) Review and Salospir (acetylsalicylic Acid) Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SERETIDE DISKUS (SERETIDE) (View Seretide Diskus (seretide) Review and Seretide Diskus (seretide) Label ), BEROVENT (BREVA) (View Berovent (breva) Review and Berovent (breva) Label ). Patient was hospitalized.

5081883-1 | Dental Operation, Excessive Granulation Tissue, Fistula, Inflammation, Oral Surgery, Osteonecrosis, Pain In Jaw, Purulent Discharge, Sequestrectomy
on Jan 25, 2006 Male patient from GERMANY , 62 years of age, weighting 174.2 lb, was diagnosed with prostate cancer metastatic, hypertension, metastases to bone and was treated with Trenantone (View Usage). Patient had the following side effects: dental operation, excessive granulation tissue, fistula (What is fistula?), inflammation, oral surgery, osteonecrosis (What is osteonecrosis?), pain in jaw, purulent discharge, sequestrectomy. Trenantone dosage: 1 Df, Q3mo. During the same period patient was treated with ENALAPRIL MALEATE (5 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), ACETYLSALICYLIC ACID SRT (100 Mg, Qd) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CASODEX (50 Mg, Qd) (View Casodex Review and Casodex Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

5073816-9 | Bone Disorder, Dental Treatment, Osteonecrosis, Tooth Abscess, Tooth Infection
Patient was taking Trenantone (View Usage). After Trenantone was administered, patient had the following side effects: bone disorder, dental treatment, osteonecrosis (What is osteonecrosis?), tooth abscess, tooth infection on May 16, 2006 from GERMANY Additional patient health information: Male patient , 60 years of age, was diagnosed with prostate cancer metastatic, metastases to bone and. Trenantone dosage: 1 Df, Q3mo. During the same period patient was treated with ZOMETA (4 Mg, Unk) (View Zometa Review and Zometa Label ).

5060888-0 | Bone Disorder, Dental Treatment, Dry Socket, Impaired Healing, Tooth Extraction, Wound Treatment
Adverse event was reported on Dec 19, 2005 by a Male patient taking Trenantone (View Usage) (Dosage: 1 Df, Q3mo) was diagnosed with prostate cancer metastatic and. Location: GERMANY , 78 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: bone disorder, dental treatment, dry socket, impaired healing, tooth extraction, wound treatment. During the same period patient was treated with ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ), ENALAPRIL MALEATE (20 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), AMINEURIN (25 Mg, Qd) (View Amineurin Review and Amineurin Label ), DURAGESIC 100 (25 Mg, Q72h) (View Duragesic-100 Review and Duragesic-100 Label ), EMSELEX (7.5 Mg, Qd) (View Emselex Review and Emselex Label ).

5035125-3 | Dental Operation, Excessive Granulation Tissue, Fistula, Inflammation, Oral Surgery, Osteomyelitis, Osteonecrosis, Pain In Jaw, Procedural Site Reaction
on Jan 25, 2006 Male patient from GERMANY , 62 years of age, weighting 174.2 lb, was diagnosed with prostate cancer metastatic, hypertension, metastases to bone and was treated with Trenantone (View Usage). Patient had the following side effects: dental operation, excessive granulation tissue, fistula (What is fistula?), inflammation, oral surgery, osteomyelitis, osteonecrosis (What is osteonecrosis?), pain in jaw, procedural site reaction. Trenantone dosage: 1 Df, Q3mo. During the same period patient was treated with ENALAPRIL (5 Mg, Qd) (View Enalapril Review and Enalapril Label ), ACETYLSALICYLIC ACID SRT (100 Mg, Qd) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CASODEX (50 Mg, Qd) (View Casodex Review and Casodex Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

4668381-1 | Anaesthesia, Bone Disorder, Bone Trimming, Dental Operation, Gingivitis, Inflammation, Jaw Disorder, Leukoplakia, Osteolysis
on Dec 29, 2004 Male patient from , 62 years of age, was diagnosed with prostate cancer metastatic, metastases to bone and was treated with Trenantone (View Usage). After Trenantone was administered, patient had the following side effects: anaesthesia, bone disorder, bone trimming, dental operation, gingivitis, inflammation, jaw disorder, leukoplakia, osteolysis. Trenantone dosage: 1 Df, Q3mo. During the same period patient was treated with CASODEX (50 Mg, Qd) (View Casodex Review and Casodex Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ). Patient was hospitalized.